Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 346 AL 360

Progress and Perspectives on the Estrogen-Microbiota-Brain Axis in Alzheimer's Disease

Wang M, Zeng Y, Jin Y, Wu J, Li J.

Neurochem Res. 2025 Nov 26;51(1):3. doi: 10.1007/s11064-025-04613-6.

Multitarget-directed ligands in Alzheimer's disease: identification of AChE and BACE1 inhibitors by in silico approaches

da Conceição RA, Barbosa MLC, de Souza AMT.

J Comput Aided Mol Des. 2025 Dec 3;40(1):7. doi: 10.1007/s10822-025-00712-2.

Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis

Gu F, Zhu J, Zhu P, Zou Z.

Asia Pac J Clin Nutr. 2025 Dec;34(6):922-940. doi: 10.6133/apjcn.202512_34(6).0007.

The Role and Therapeutic Potential of the cGAS-STING Signaling Pathway in Alzheimer's Disease

Li X, Gao W, Ye Q, Li H.

Brain Behav. 2025 Dec;15(12):e71130. doi: 10.1002/brb3.71130.

A value assessment of patient-level outcomes and productivity loss for intravenous and subcutaneous lecanemab for patients with early Alzheimer's disease

Ressa R, Ettinger J, Chowdhury E, Graham L, Ndirangu K, Mancebo JZ, Bodnar C.

J Med Econ. 2025 Dec 24;29(1):118-134. doi: 10.1080/13696998.2025.2609499. Epub 2026 Jan 5.

[Research progress on prevention and treatment of Alzheimer's disease with Danggui Shaoyao San]

Sun CX, Han XY, Xiao YT, Liu YX, Ye TY.

Zhongguo Zhong Yao Za Zhi. 2025 Nov;50(22):6215-6226. doi: 10.19540/j.cnki.cjcmm.20250626.601.

Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer's Disease

Pavlov S, Prajapati SK, Yadav D, Marcano-Rodriguez A, Yadav H, Jain S.

Biomolecules. 2025 Dec 19;16(1):7. doi: 10.3390/biom16010007.

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Arar S, Haque MA, Kayed R.

Proteins. 2025 Aug;93(8):1314-1329. doi: 10.1002/prot.26561. Epub 2023 Aug 2.

Lipid-based Nanomedicine for Alzheimer's Disease: A Comprehensive Review of Recent Advances

Dhankhar S, Garg N, Sharma H, Chauhan S, Saini M.

Pharm Nanotechnol. 2025;13(4):695-711. doi: 10.2174/0122117385300234240522100826.

Beta-site APP-cleaving Enzyme-1 Inhibitory Role of Natural Flavonoids in the Treatment of Alzheimer's Disease

Singh S, Kushwaha V, Sisodia S, Kumar S, Sahu KK.

Cent Nerv Syst Agents Med Chem. 2025;25(1):39-48. doi: 10.2174/0118715249315049240710063455.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.

Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.

Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease

Liu Y, Zhang Z, Zhu Z, Yang Y, Peng W, Chen Q, Mak S, Tism KW, Pi R.

Mini Rev Med Chem. 2025;25(2):163-175. doi: 10.2174/0113895575330648240819112435.

Basic approach on the protective effects of hesperidin and naringin in Alzheimer's disease

Kuşi M, Becer E, Vatansever HS.

Nutr Neurosci. 2025 May;28(5):550-562. doi: 10.1080/1028415X.2024.2397136. Epub 2024 Sep 3.

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Tang S, Zhang Y, Botchway BOA, Wang X, Huang M, Liu X.

Mol Neurobiol. 2025 Mar;62(3):3493-3507. doi: 10.1007/s12035-024-04498-6. Epub 2024 Sep 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias